Today’s headline is that the Cancer Drugs Fund, which was announced by the Tories in 2010 and ran until 2016, was a ‘huge waste of money’. The Annals of Oncology journal has published a study led by Professor Richard Sullivan of King’s College London, who also described the Fund as a ‘major policy error’.
The Conservatives thought they could pick up a few votes in 2010 by promising to fund expensive cancer drugs that the NHS was not funding, and the CDF was the result. It funded cancer patients to receive medications which had not yet been approved by the National Institute of Health and Care Excellence (NICE). Launched in 2011 with a budget of £200 million, the Fund was supposed to be a stopgap while alternatives were developed, and was initially scheduled to run until 2014. However, the government did not pursue its alternative policy, the ominous-sounding Value-Based Pricing, and instead extended the CDF until 2016, by which time it had been denounced by the Cancer Taskforce and the National Audit Office as unsustainable, and some doctors - including Richard Sullivan - were calling it an ‘unethical fix’ and a ‘waste of public money’. Still the Conservatives promised in their 2015 election manifesto that ‘We will continue to invest in our lifesaving Cancer Drugs Fund’ and issued the poster pictured, only to scrap the CDF a year later, absorbing it into NICE.